Then, we established a CML-like disease model by retroviral BCR–ABL1 transduction into HSCs isolated from WT and Gdpd3-deficent mice, followed by bone marrow transplantation (BMT) into recipient mice. This evidence concerns the gene GDPD3 and chronic myelogenous leukemia, BCR-ABL1 positive.